These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36579304)

  • 1. The Role of Civil Society in Mobilizing Human Rights Struggles for Essential Medicines: A Critique from HIV/AIDS to COVID-19.
    Sekalala S; Rawson B
    Health Hum Rights; 2022 Dec; 24(2):177-189. PubMed ID: 36579304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders.
    Kohler J; Wong A; Tailor L
    Health Hum Rights; 2022 Dec; 24(2):159-175. PubMed ID: 36579316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
    Hoen E'; Berger J; Calmy A; Moon S
    J Int AIDS Soc; 2011 Mar; 14():15. PubMed ID: 21439089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform.
    Chattu VK; Singh B; Kaur J; Jakovljevic M
    Biomed Res Int; 2021; 2021():6658070. PubMed ID: 34485525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
    Sekalala S; Forman L; Hodgson T; Mulumba M; Namyalo-Ganafa H; Meier BM
    BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34253631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
    Fajber K
    Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership - a qualitative study of policy actors' views.
    Townsend B
    Global Health; 2021 Jul; 17(1):78. PubMed ID: 34238347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
    Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P
    BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Commissioners of and collaborators with the International AIDS Society–Lancet Commission on Health and Human Rights
    Lancet; 2021 Apr; 397(10284):1524-1527. PubMed ID: 33773117
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying a human rights-based approach to obesity for States and civil society.
    Patterson D; Buse K; Magnusson R; Toebes B
    Obes Rev; 2019 Nov; 20 Suppl 2():45-56. PubMed ID: 31297936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
    Galvão J
    Am J Public Health; 2005 Jul; 95(7):1110-6. PubMed ID: 15933238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
    Amimo F; Lambert B; Magit A; Hashizume M
    Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.
    Mermelstein S; Stevens H
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.
    Nunn A; Fonseca ED; Gruskin S
    Glob Public Health; 2009; 4(2):131-49. PubMed ID: 19333805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries.
    Kishore SP; Kolappa K; Jarvis JD; Park PH; Belt R; Balasubramaniam T; Kiddell-Monroe R
    Health Aff (Millwood); 2015 Sep; 34(9):1569-77. PubMed ID: 26355060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Needle in a Haystack? Human Rights Framing at the World Trade Organization for Access to COVID-19 Vaccines.
    Perehudoff K; Qazilbash H; de Vries KF
    Health Hum Rights; 2022 Dec; 24(2):141-157. PubMed ID: 36579306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
    Allard Soto R
    Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.